Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Rios Romenets

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 1, 2022
Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia TrialClara Vila-Castelar, Pierre N Tariot, Kaycee M Sink, et al.
Neuroimage. Clinical|July 12, 2021
PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer's disease-causing Presenilin-1 E280A mutation carriersValentina Ghisays, Francisco Lopera, Dhruman D Goradia, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 18, 2020
Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal-Dominant Alzheimer's Disease Colombia TrialSilvia Rios-Romenets, Francisco Lopera, Kaycee M Sink, et al.
Nature Medicine|November 6, 2019
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case reportJoseph F Arboleda-Velasquez, Francisco Lopera, Michael O'Hare, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 1, 2022
Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia TrialClara Vila-Castelar, Pierre N Tariot, Kaycee M Sink, et al.
Neuroimage. Clinical|July 12, 2021
PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer's disease-causing Presenilin-1 E280A mutation carriersValentina Ghisays, Francisco Lopera, Dhruman D Goradia, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 18, 2020
Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal-Dominant Alzheimer's Disease Colombia TrialSilvia Rios-Romenets, Francisco Lopera, Kaycee M Sink, et al.
Nature Medicine|November 6, 2019
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case reportJoseph F Arboleda-Velasquez, Francisco Lopera, Michael O'Hare, et al.
Pageof 3